Old Web
English
Sign In
Acemap
>
Paper
>
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. A new drug class for the treatment of hypercholesterolemia
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. A new drug class for the treatment of hypercholesterolemia
2017
Emilio Ortega Martínez de Victoria
Keywords:
Kexin
Subtilisin
Drug class
PCSK9 Inhibitors
Pharmacology
Proprotein convertase
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
25
References
0
Citations
NaN
KQI
[]